EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity

Chenyin Chu, Yihan Wang, Liwei Ma, Chloe A Mutimer, Guangyan Ji, Huiyu Shi, Nawaf Yassi, Colin L Masters, Benjamin Goudey, Liang Jin, Yijun Pan iD

Alzheimer's & Dementia · 2025-03 · 21 (3)

DOI: 10.1002/alz.14583 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.03.2025. Verfasst von Chenyin Chu und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Severity of Illness Index, Machine Learning. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Association, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Cerebral amyloid angiopathy (CAA) is a cerebrovascular condition, the severity of which can only be determined post mortem . Here, we developed machine learning models, the Florey CAA Score (FCAAS), to predict CAA severity (none/mild/moderate/severe). METHODS Building on an auto‐score‐ordinal algorithm, the FCAAS models were developed and validated using data collected by three cohort studies of aging and dementia. The developed FCAAS models were digitized as a web‐based tool. A pilot trial was conducted using this web‐based tool. RESULTS The FCAAS‐4 achieved a mean area under the receiver operating characteristic curve (AUC‐ROC) of 0.74 (95% confidence interval: 0.71–0.77) and a Harrell generalized c‐index of 0.72 (0.70–0.75). Pilot trial results obtained a mean AUC‐ROC of 0.82 (0.71–0.85) and Harrell generalized c‐index 0.79 (0.73–0.82). DISCUSSION The FCAAS models demonstrate a promising performance in predicting CAA severity. This framework holds the potential for predicting development of amyloid‐related imaging abnormalities (ARIAs), given the CAA–ARIAs link. Highlights The severity of cerebral amyloid angiopathy (CAA) can only be determined post mortem . A web tool, the Florey CAA Score (FCAAS), was developed to predict CAA severity. The FCAAS holds the potential to be used for CAA risk stratification in clinics. CAA is linked to increased risk of amyloid‐related imaging abnormalities (ARIAs). The framework used by FCAAS can possibly be adapted to predict ARIAs risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Amyloid AngiopathySeverity of Illness IndexMachine LearningHumansMaleFemaleAgedPilot ProjectsAged, 80 and overCohort StudiesROC Curve

Stichwörter der Autor:innen

AutoScore ordinal algorithmamyloid‐related imaging abnormalitiescerebral amyloid angiopathymachine learningrisk prediction

Autor:innen und Institutionen

  • The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.
  • Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • The ARC Training Centre in Cognitive Computing for Medical Technologies, The University of Melbourne, Calton, Victoria, Australia.

ORCID-Profile: Yijun Pan

Förderung

  • NIA NIH HHS
  • Alzheimer's Association
  • National Health and Medical Research Council

Zitieren

APA

Chu, C., Wang, Y., Ma, L., Mutimer, C. A., Ji, G., Shi, H., Yassi, N., Masters, C. L., Goudey, B., Jin, L., & Pan, Y. (2025). Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity. Alzheimer's & Dementia, 21(3). https://doi.org/10.1002/alz.14583

Vancouver

Chu C, Wang Y, Ma L, Mutimer CA, Ji G, Shi H, et al. Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity. Alzheimer's & Dementia. 2025;21(3). doi:10.1002/alz.14583

BibTeX
@article{Chu2025,
  author = {Chu, Chenyin and Wang, Yihan and Ma, Liwei and Mutimer, Chloe A and Ji, Guangyan and Shi, Huiyu and Yassi, Nawaf and Masters, Colin L and Goudey, Benjamin and Jin, Liang and Pan, Yijun},
  title = {Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {3},
  doi = {10.1002/alz.14583}
}
Kostenlos starten →